See also this year's filing and all EDGAR filings for this company.
PDF Report 0001807901_2021_Pandion_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001807901, Pandion Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 223,939,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,423,000 |
| 3 | remainder_Assets | 502,000 |
| 4 | LiabilitiesCurrent | 8,856,000 |
| 5 | LiabilitiesNoncurrent | 4,278,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,803,000 |
| 9 | ResearchAndDevelopmentExpense | 33,905,000 |
| 10 | remainder_Expenses | 245,000 |
| 11 | remainder_Revenues | 8,779,000 |
| 12 | remainder_NetIncome | 69,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 227,864,000 |
| 1 | Liabilities | 13,134,000 |
| 2 | Expenses | 46,953,000 |
| 3 | Revenues | 8,779,000 |
| 4 | StockholdersEquity | 214,730,000 |
| 5 | NetIncome | -38,105,000 |
| 6 | ComprehensiveNetIncome | -38,105,000 |
| 7 | BaseVar | 148,399,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.57 |
| 9 | EconomicCapitalRatio | 4.08 |